Cancer · Austria
Myeloproliferative neoplasms
How is it diagnosed today? A blood test counts your blood cells. NCI PDQ
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.10 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Venesection, low-dose aspirin, hydroxyurea. NCI PDQ
7 medicines are approved for this disease in Austria:
- Anagrelide (Anagrelide Viatris, Xagrid, Agrylin) – approved in 2004
- Fedratinib (Inrebic) – approved in 2021
- Imatinib (Glivec, Imatinib Accord, Imatinib Teva) – approved in 2001
- Momelotinib (Omjjara, Ojjaara) – approved in 2024
- Peginterferon alfa-2a (Pegasys) – approved in 2002
- Ropeginterferon alfa-2b (Besremi, BESREMi) – approved in 2019
- Ruxolitinib (Jakavi, Ruxolitinib Viatris, Jakafi) – approved in 2012
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (5)
- Hydroxycarbamide (Hydrea) – approved for it in France
- Luspatercept (Reblozyl) – approved for it in the US
- Pacritinib (Vonjo) – approved for it in the US
- Pipobroman (Vercyte) – approved for it in France
- Rusfertide (Mimrylo) – approved for it in the US
Being tested in people
10 open trials in Austria, 189 worldwide. See the trials
- 81-mg aspirin once daily (Phase 3)
- 81-mg aspirin twice daily (Phase 3)
- ACE-536 (Phase 3)
- Anagrelide (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
1 open trial in Austria with these filters
Long-term asciminib treatment for people with chronic myeloid leukemia
NCT04877522 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Linz – Ordensklinikum Linz GmbH
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Ages 7 to 100
Contact the trial team
Available abroad (36 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Follows people with Philadelphia-negative myeloproliferative neoplasms over time
NCT07863466 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – Ospedale Maggiore Policlinico
Age 16 and over
Contact the trial teamTests two ways to prevent graft-versus-host disease after donor stem cell transplant
NCT04888741 · ClinicalTrials.gov
Countries: United Kingdom
- Birmingham, United Kingdom – Queen Elizabeth Hospital
- Bristol, United Kingdom – Bristol Haematology and Oncology Centre
- Cambridge, United Kingdom – Addenbrookes Hospital
Ages 16 to 70
Contact the trial teamRegistry collecting data on rare blood cell overgrowth diseases in children
NCT07410247 · ClinicalTrials.gov
Countries: Germany
- Erlangen, Germany – Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany
Ages 0 to 17
Contact the trial teamTesting a lab platform that analyzes samples from people with blood cancers
NCT07445438 · ClinicalTrials.gov
Countries: Italy
- Parma, Italy – University of Parma
Age 2 and over
Contact the trial teamGenetic and molecular testing of samples from people with blood cancers
NCT07445984 · ClinicalTrials.gov
Countries: Italy
- Parma, Italy – University of Parma
Age 1 and over
Contact the trial teamLab testing of tumor samples to profile high-risk blood and solid cancers
NCT07403630 · ClinicalTrials.gov
Countries: Italy
- Palermo, Italy – AO Riuniti Villa Sofia-Cervello di Palermo
- Perugia, Italy – University of Perugia
Age 1 and over
Contact the trial teamStudy of young people with myeloproliferative neoplasia and their outcomes
NCT06715267 · ClinicalTrials.gov
Countries: France
- Brest, France – CHU de Brest
Ages 0 to 30
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCollects data and samples from patients with leukemia and related blood disorders
NCT05326919 · ClinicalTrials.gov
Countries: France
- Bobigny, France – Hopital Avicenne
- Paris, France – Hopital Robert Debre
- Paris, France – Hopital Saint Louis
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests pacritinib in people with myelodysplastic syndromes
NCT06303193 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 12 to 120
Contact the trial teamA standard note template for doctors caring for people with polycythemia vera
NCT07734272 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Mass General Brigham Cancer Institute
No age limit given in the registry
Contact the trial teamTesting dexrazoxane to protect the heart during chemotherapy for blood cancers
NCT03589729 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Age 12 and over
Contact the trial teamTests natural killer cell therapy after cord blood transplant in blood cancers
NCT02727803 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Ages 15 to 80
Contact the trial teamStudies how the body processes venetoclax tablets crushed into a liquid in young patients
NCT06131801 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Children's Healthcare of Atlanta - Arthur M Blank Hospital
- Aurora, United States – Children's Hospital Colorado
- Cincinnati, United States – Cincinnati Children's Hospital Medical Center
Ages 0 to 38
Contact the trial teamCord blood stem cell transplant with chemotherapy in high-risk blood cancers
NCT06013423 · ClinicalTrials.gov
Countries: United States
- Seattle, United States – Fred Hutch/University of Washington Cancer Consortium
Ages 0 to 65
Contact the trial teamTwo Ways to Reduce Graft Versus Host Disease After Stem Cell Transplant
NCT03970096 · ClinicalTrials.gov
Countries: United States
- Pittsburgh, United States – University of Pittsburgh Cancer Institute (UPCI)
- Seattle, United States – Fred Hutch/University of Washington Cancer Consortium
- Tampa, United States – Moffitt Cancer Center
Ages 1 to 60
Contact the trial teamBrain MRI Scans and Memory Tests in Young People With Acute Leukemia
NCT06421155 · ClinicalTrials.gov
Countries: United States
- Cleveland, United States – University Hospitals Cleveland Medical Center, Rainbow Babies & Children's Hospital, Case Comprehensive Cancer Center
Up to age 30
Contact the trial teamSurvey of doctors on how they diagnose and treat polycythemia vera
NCT07868081 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamPregnancy outcomes in women with myeloproliferative neoplasms managed by a risk-based plan
NCT07832513 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamTests edetate calcium disodium or succimer with chemotherapy in leukemia or myelodysplastic syndrome
NCT03630991 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Age 1 and over
Contact the trial teamHalf-matched donor stem cell transplant in people with myelofibrosis
NCT06674382 · ClinicalTrials.gov
Countries: China
- Beijing, China – Peking University People's Hospital
No age limit given in the registry
Contact the trial teamWJ01024 alone or with ruxolitinib in people with myelofibrosis
NCT07802405 · ClinicalTrials.gov
Countries: China
- Zhengzhou, China – Henan Cancer Hospital
Age 0 and over
Contact the trial teamGathers health information from younger patients with cancer over time
NCT02402244 · ClinicalTrials.gov
Countries: Australia, Canada, New Zealand and 3 more
- Clayton, Australia – Monash Medical Center-Clayton Campus
- North Adelaide, Australia – Women's and Children's Hospital-Adelaide
- Parkville, Australia – Royal Children's Hospital
Up to age 25
Contact the trial teamStudying what causes blood and bone marrow cancers, using samples from patients
NCT01728402 · ClinicalTrials.gov
Countries: United States
- Portland, United States – OHSU Knight Cancer Institute
Age 1 and over
Contact the trial teamStem cell transplant with milder preparation for blood cancers
NCT05805605 · ClinicalTrials.gov
Countries: United States
- Minneapolis, United States – Masonic Cancer Center at University of Minnesota
Up to age 75
Contact the trial teamStem cell transplant with two conditioning approaches for blood cancers
NCT03314974 · ClinicalTrials.gov
Countries: United States
- Minneapolis, United States – Masonic Cancer Center at University of Minnesota
Up to age 60
Contact the trial teamTests immune NK cells with IL-2 after myeloid blood cancer returns following transplant
NCT04024761 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Dana-Farber Cancer Institute
- Boston, United States – Boston Children's Hospital
Age 12 and over
Contact the trial teamTesting oral LP-118 in people with returned or non-responding blood cancers
NCT04771572 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Dana-Farber Cancer Institute
- Chapel Hill, United States – University of North Carolina
- Chicago, United States – University of Chicago
Age 13 and over
Contact the trial teamTests CD34-selected stem cell infusion in people with blood cancers and graft problems
NCT06047886 · ClinicalTrials.gov
Countries: United States
- Birmingham, United States – University of Alabama at Birmingham
Ages 0 to 75
Contact the trial teamCord blood transplant for young people with blood cancers or other disorders
NCT04644016 · ClinicalTrials.gov
Countries: United States
- New York, United States – Memorial Sloan-Kettering Cancer Center
Up to age 21
Contact the trial teamFollows people with blood diseases in China to study treatment and outcomes
NCT04645199 · ClinicalTrials.gov
Countries: China
- Tianjin, China – Institute of Hematology & Blood Diseases Hospital
No age limit given in the registry
Contact the trial teamReal-world study of ropeginterferon alfa-2b in people with polycythemia vera
NCT07282132 · ClinicalTrials.gov
No age limit given in the registry
Contact the trial teamRegistry of an AI tool used to search for cancer trials
NCT03452774 · ClinicalTrials.gov
Countries: Puerto Rico, United States
- San Juan, Puerto Rico – hospital not given
- Albuquerque, United States – hospital not given
- Ann Arbor, United States – hospital not given
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamInhaled peginterferon α-2b for children with RSV pneumonia
NCT06881056 · ClinicalTrials.gov
Countries: China
- Chengdu, China – Chengdu Women's and Children's Central Hospital
- Chengdu, China – West China Second University Hospital of Sichuan University
Ages 1 to 3
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamBlood cell measurements in people with myeloproliferative neoplasms
NCT06753279 · ClinicalTrials.gov
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCollects health information from people with blood cell disorders called myeloproliferative neoplasms
NCT02760238 · ClinicalTrials.gov
Countries: Canada
- Toronto, Canada – Princess Margaret Cancer Centre
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests olverembatinib in people with FGFR1-rearranged blood cancers
NCT05521204 · ClinicalTrials.gov
Countries: China
- Suzhou, China – First Affiliated Hospital of Soochow University
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- CAR-T Targeting of Mutant Calreticulin Selectively Eradicates Myeloproliferative Neoplasm-Sustaining Stem Cells.Blood · 2026-11-12
- In peopleHow I diagnose myeloid or lymphoid neoplasms with tyrosine kinase gene fusions.Am J Clin Pathol · 2026-11-04
- Low dose pre-transplant splenic radiotherapy for myeloproliferative neoplasms.Leuk Lymphoma · 2026-11-11
- Transfusion-related cost and time burden offsets associated with pacritinib versus best available therapy in patients with myelofibrosis: an economic evaluation based on the PERSIST-2 trial.Future Oncol · 2026-11-11
- The new Iron Age in polycythemia vera.Blood · 2026-11-12
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
- MPN Austria
Austrian patient association for people with myeloproliferative neoplasms (MPN) and their relatives. Member of MPNAN.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (8)
- MPN Advocacy & Education International
Nonprofit providing education and advocacy for people living with myeloproliferative neoplasms.
- MPN Research Foundation
Foundation funding research into myeloproliferative neoplasms and supporting the MPN patient community.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- MPN Advocates Network
Global network of MPN patient groups: advocacy education, MPN Awareness Day, global patient survey, webinars, MPN Horizons conference.
- Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.